πŸ‡ΊπŸ‡Έ FDA
Patent

US 9333237

Bone morphogenic protein binding peptide

granted A61KA61K35/32A61K38/10

Quick answer

US patent 9333237 (Bone morphogenic protein binding peptide) held by The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS)
Grant date
Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K35/32, A61K38/10, A61K38/1709, A61K38/1841